Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03298451
Brief Title: Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma (HIMALAYA)

First Submitted : September 19, 2017
First Submitted that Met QC Criteria : September 26, 2017
First Posted : October 2, 2017

Last Update Submitted that Met QC Criteria : October 31, 2019
Last Update Posted : November 1, 2019